Derma Sciences, Inc. is Pleased to Have MEDIHONEY Recognized as a Finalist for Novation’s 2011 Innovative Technology Award

PRINCETON, N.J.--(BUSINESS WIRE)--Derma Sciences, Inc. (Nasdaq: DSCI), a medical device and pharmaceutical company focused on advanced wound care, today announced that at the Novation Supplier Summit Conference in February the Company’s MEDIHONEY was recognized as a finalist for the Novation 2011 Innovative Technology Award. Novation is the leading health care supply contracting company for the members of VHA Inc. and UHC, two national health care alliances, and Provista, LLC.

MORE ON THIS TOPIC